2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Breast Neoplasms
11
Agnosia
6
Urinary Bladder Neoplasms
4
Pain, Postoperative
4
Neoplasms
4
Lung Neoplasms
4
Pancreatic Neoplasms
3
Recurrence
2
Neoplastic Cells, Circulating
2
Neoplasm Metastasis
2
Liver Neoplasms
2
Leiomyoma
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Anesthesia
2
Acute Pain
2
Uterine Neoplasms
1
Uterine Hemorrhage
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Respiratory Aspiration
1
Pulmonary Atelectasis
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Postoperative Nausea and Vomiting
1
Postoperative Hemorrhage
1
Postoperative Complications
1
Pneumothorax
1
Pleural Neoplasms
1
Interventions
Cisplatin
57
Pemetrexed
46
pembrolizumab
18
Nivolumab
15
Carboplatin
15
Gemcitabine
14
Cyclophosphamide
13
Radiotherapy
10
Drug Therapy
9
atezolizumab
8
Platinum
7
Ipilimumab
7
Doxorubicin
7
durvalumab
6
1,2-diaminocyclohexaneplatinum II citrate
6
tremelimumab
5
sodium thiosulfate
5
Vinorelbine
5
Radiotherapy, Intensity-Modulated
5
Interleukin-2
5
Chemotherapy, Adjuvant
5
Cerebral Decortication
5
sargramostim
4
fludarabine
4
defactinib
4
aldesleukin
4
tumor necrosis factor-alpha, CNGRC fusion protein, human
3
cediranib
3
Photochemotherapy
3
Neoadjuvant Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Anesthesia, General
×
Clear all
NCT05077111
2021-10-14
VATS
Ain Shams University
Phase 4
Unknown
40 enrolled